SureTrader Nadex Advertisement SureTrader
Home > Boards > US Listed > Biotechs > Cellular Biomedicine Group, Inc. (CBMG)

EastBridge Investment Group's Wholly Owned Subsidiary, General Farms

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
pappi Member Profile
Member Level 
Followed By 8
Posts 1,610
Boards Moderated 0
Alias Born 01/11/04
160x600 placeholder
Current Report Filing (8-k) "Edgar (US Regulatory)" - 4/10/2017 2:42:24 PM
Cellular Biomedicine Group (CBMG) and GE Healthcare Life Sciences China Announce Strategic Partnership to Establish Joint Tec... "GlobeNewswire Inc." - 4/10/2017 8:05:30 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 4/3/2017 7:37:31 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 4/3/2017 7:37:31 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 4/3/2017 7:37:06 PM
Cellular Biomedicine Group (CBMG) Announces Completion of Wuxi GMP Facility Expansion "GlobeNewswire Inc." - 3/30/2017 8:49:17 AM
Revised Proxy Soliciting Materials (definitive) (defr14a) "Edgar (US Regulatory)" - 3/23/2017 3:49:35 PM
Additional Proxy Soliciting Materials (definitive) (defa14a) "Edgar (US Regulatory)" - 3/21/2017 9:21:59 AM
Cellular Biomedicine Group (CBMG) Announces Annual Meeting of Stockholders "GlobeNewswire Inc." - 3/21/2017 8:15:00 AM
Proxy Statement (definitive) (def 14a) "Edgar (US Regulatory)" - 3/17/2017 5:00:56 PM
Amended Annual Report (10-k/a) "Edgar (US Regulatory)" - 3/14/2017 4:14:36 PM
Cellular Biomedicine Group Reports Full-Year 2016 Financial Results and Recent Operational Progress "GlobeNewswire Inc." - 3/14/2017 6:00:00 AM
Annual Report (10-k) "Edgar (US Regulatory)" - 3/13/2017 4:19:39 PM
Proxy Soliciting Materials (revised) (prer14a) "Edgar (US Regulatory)" - 3/3/2017 5:22:13 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 2/27/2017 8:01:29 AM
Cellular Biomedicine Group Awarded $2.29 Million Grant from the California Institute for Regenerative Medicine (CIRM) to Fund... "GlobeNewswire Inc." - 2/27/2017 8:00:00 AM
Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a) "Edgar (US Regulatory)" - 2/9/2017 5:05:51 PM
Cellular Biomedicine Group (CBMG) to Present at the 19th BIO CEO & Investor Conference on February 13, 2017 "GlobeNewswire Inc." - 2/7/2017 8:31:04 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 1/23/2017 3:43:16 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 1/9/2017 6:32:30 AM
Cellular Biomedicine Group (CBMG) Approved to Commence Phase I Trial (CALL-1) for C-CAR011 in Adult Patients with Relapsed or... "GlobeNewswire Inc." - 1/9/2017 6:11:22 AM
Cellular Biomedicine Group (CBMG) to Present at the 9th Annual Biotech Showcase in San Francisco "GlobeNewswire Inc." - 1/4/2017 8:00:00 AM
Cellular Biomedicine Group (CBMG) Expands Cell Production With Capacity to Produce CAR-T Therapies to Treat 10,000 Cancer Pa... "GlobeNewswire Inc." - 1/3/2017 8:00:00 AM
Cellular Biomedicine Group Announces Three-Month Interim Safety Data from Phase I Clinical Trial for AlloJoin™ Off-the-She... "GlobeNewswire Inc." - 12/9/2016 8:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 12/8/2016 11:02:58 AM
pappi Member Level  Wednesday, 12/05/07 01:12:37 PM
Re: None
Post # of 2721 
EastBridge Investment Group's Wholly Owned Subsidiary, General Farms Corp, to Be Acquired by Rhino Two Horns, Malaysia
Wednesday December 5, 8:00 am ET


PHOENIX, AZ--(MARKET WIRE)--Dec 5, 2007 -- EastBridge Investment Group (EBIG) (OTC BB:EBIG.OB - News) today announced that it has signed a definitive agreement with Rhino Two Horns Sdn. Bhd, Malaysia for it to acquire General Farms Corp and assume effective control.

General Farms is a wholly owned subsidiary of EastBridge. A stock dividend of 5% of General Farm's common stock, or 10,000,000 shares, will be distributed to EastBridge's shareholders of record as of Nov 16, 2007. Under the terms of the share exchange agreement, the new stock ownership structure is: 15% owned by EastBridge and 5% owned by EastBridge's shareholders of record as of Nov 16, 2007. Rhino's beneficiaries will own the remaining 80%. The closing is expected to happen in ten working days.

Mr. Norm Klein, COO and CFO of EastBridge, commented, "We are committed to taking Rhino Two Horns Sdn. Bhd, Malaysia public in the U.S. as soon as practicable in 2008. We are quite impressed with the progress made by Rhino's management since August, 2007."

Rhino Two Horns, based in Malaysia, is first to market all natural energy sports drinks containing a unique formulation that re-hydrates faster than water and assists the body to refresh and recover from intense sporting activities in the sub-tropical climates. The current TWO HORNS(TM) product range includes Energy 250, and Ultra Sports 500 beverages. New products featuring the 'super fruit' Acai berry, called Acai Energy 250 and R3HYDR8(TM) 250 are being prepared for launch in the 1st quarter 2008. The company is currently negotiating to market its products to China, U.S. and Sri Lanka. More information is available at www.rhinotwohorns.com.

EastBridge Investment Group focuses on small to medium-size high-growth companies in China and India offering IPOs, Joint Ventures and Merchant Banking services. The Company targets industries in electronics, real estate, auto, metal, energy, environmental, bioscience and food retail distribution. To learn more about EastBridge Investment Group go to our web site: www.EbigCorp.com. To receive EBIG's email alert, send a blank email to info@EbigCorp.com.

The information in this news release includes certain forward-looking statements that are based upon assumptions that in the future may prove not to have been accurate and are subject to significant risks and uncertainties, including statements to the future financial performance of the Company. Although the Company believes that the expectations reflected in its forward-looking statements are reasonable, it can give no assurance that such expectation or any of its forward-looking statements will prove to be correct. Factors that could cause results to differ include, but are not limited to, successful performance of internal plans, fluctuations in foreign currency exchange, the impact of competitive services and pricing, or general economic risks and uncertainties.



Contact:
Company Contact:
Norm Klein
EastBridge Investment Group Corp.
480-966-2020
480-966-0808 (fax)
Email Contact

Investor Relations Contact:
Jack Eversull
The Eversull Group, Inc.
972-378-7917
972-378-7981 (fax)
Email Contact



--------------------------------------------------------------------------------
Source: EastBridge Investment Group




SureTrader
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist